Audiologists in Oconomowoc, WI Accepting Medicare

3 Audiologists found. Showing 1 - 3

Hearing Center, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 888 Thackeray Trl, Ste 107, Oconomowoc, WI 53066 Phone: 262-567-7639    Fax: 262-567-7476

Dr. Gerard L. Kupperman, PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 888 Thackeray Trl, Oconomowoc, WI 53066 Phone: 262-567-7639    Fax: 262-567-7476

Ms. Ann M Kiesow, MA-CCCA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 915 Summit Ave, Oconomowoc, WI 53066 Phone: 262-569-2300    Fax: 262-569-2266

News Archive

NIST panel provides tailored recommendations to accelerate adoption of pediatric EHRs

To speed development and adoption of electronic health records for pediatrics, a group of experts from industry, academia and government convened by the National Institute of Standards and Technology has focused its attention on three key audiences-records-system vendors and developers, small-group pediatric medical practices and children's hospitals.

Altheus Therapeutics announces completion of Zoenasa phase I trial for ulcerative colitis

Altheus Therapeutics, announced that it has completed a two dose, double-blind, active-controlled Phase I clinical trial of the safety and tolerability of Zoenasa Rectal Suspension in adult patients with left-sided, or distal, ulcerative colitis.

Countering neuroinflammation is indeed a potential therapeutic strategy for Alzheimer's

New research proves the validity of one of the most promising approaches for combating Alzheimer's disease (AD) with medicines that treat not just some of the symptoms, but actually stop or prevent the disease itself, scientists are reporting. The study, in the journal ACS Medicinal Chemistry Letters, also identifies a potential new oral drug that the scientists say could lead the way.

LEO Pharma gains access to Intomics' biological data analysis expertises

Today, Intomics A/S and LEO Pharma A/S announced a collaboration under which LEO Pharma gains access to Intomics' unique biological data analysis expertises. The recently founded spin-off company from The Danish Technical University, Intomics, has methods and tools for use in LEO Pharma's early drug discovery.

Alnylam Pharmaceuticals publishes encouraging results from Phase II GEMINI study in PNAS

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has published results from its Phase II GEMINI study in the Proceedings of the National Academy of Sciences (PNAS). These data, previously presented at the International Symposium on Respiratory Viral Infections in Singapore in 2008, showed human proof of concept with an RNAi therapeutic in a randomized, double blind, placebo-controlled study.

Read more Medical News

› Verified 4 days ago